These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18194300)

  • 1. The risk of newly diagnosed asthma in migraineurs with or without previous triptan prescriptions.
    Becker C; Brobert GP; Almqvist PM; Johansson S; Jick SS; Meier CR
    Headache; 2008 Apr; 48(4):606-10. PubMed ID: 18194300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptan use as a function of cardiovascular risk. A population-based study.
    Bigal ME; Golden W; Buse D; Chen YT; Lipton RB
    Headache; 2010 Feb; 50(2):256-63. PubMed ID: 20039953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of ischemic complications related to the intensity of triptan and ergotamine use.
    Wammes-van der Heijden EA; Rahimtoola H; Leufkens HG; Tijssen CC; Egberts AC
    Neurology; 2006 Oct; 67(7):1128-34. PubMed ID: 17030745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between migraine and asthma: matched case-control study.
    Davey G; Sedgwick P; Maier W; Visick G; Strachan DP; Anderson HR
    Br J Gen Pract; 2002 Sep; 52(482):723-7. PubMed ID: 12236275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migraine, triptans, and the risk of developing rosacea: a population-based study within the United Kingdom.
    Spoendlin J; Voegel JJ; Jick SS; Meier CR
    J Am Acad Dermatol; 2013 Sep; 69(3):399-406. PubMed ID: 23643255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates and predictors of starting a triptan: results from the American Migraine Prevalence and Prevention Study.
    Bigal ME; Buse DC; Chen YT; Golden W; Serrano D; Chu MK; Lipton RB
    Headache; 2010 Oct; 50(9):1440-8. PubMed ID: 20533956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risk of obstructive airways disease in a glaucoma population.
    Huerta C; García Rodríguez LA; Möller CS; Arellano FM
    Pharmacoepidemiol Drug Saf; 2001; 10(2):157-63. PubMed ID: 11499855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a 2-year retrospective cohort study of newly prescribed triptan users in European nationwide practice databases.
    Ng-Mak DS; Chen YT; Ho TW; Stanford B; Roset M
    Cephalalgia; 2012 Sep; 32(12):875-87. PubMed ID: 22833612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-dose sumatriptan and naproxen in poor responders to triptans with a short half-life.
    Mathew NT; Landy S; Stark S; Tietjen GE; Derosier FJ; White J; Lener SE; Bukenya D
    Headache; 2009 Jul; 49(7):971-82. PubMed ID: 19486178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triptan persistency among newly initiated users in a pharmacy claims database.
    Katić BJ; Rajagopalan S; Ho TW; Chen YT; Hu XH
    Cephalalgia; 2011 Mar; 31(4):488-500. PubMed ID: 20937605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people.
    Dekker F; Wiendels NJ; de Valk V; van der Vliet C; Knuistingh Neven A; Assendelft WJ; Ferrari MD
    Cephalalgia; 2011 Jun; 31(8):943-52. PubMed ID: 21593190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migraine is associated with menorrhagia and endometriosis.
    Tietjen GE; Conway A; Utley C; Gunning WT; Herial NA
    Headache; 2006 Mar; 46(3):422-8. PubMed ID: 16618258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between use of thiazolidinediones or other oral antidiabetics and psoriasis: A population based case-control study.
    Brauchli YB; Jick SS; Curtin F; Meier CR
    J Am Acad Dermatol; 2008 Mar; 58(3):421-9. PubMed ID: 18194825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Migraine and the risk of stroke, TIA, or death in the UK (CME).
    Becker C; Brobert GP; Almqvist PM; Johansson S; Jick SS; Meier CR
    Headache; 2007; 47(10):1374-84. PubMed ID: 18052947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triptans: low utilization and high turnover in the general population.
    Panconesi A; Pavone E; Franchini M; Mennuti N; Bartolozzi M; Guidi L; Banfi R
    Cephalalgia; 2010 May; 30(5):576-81. PubMed ID: 19732070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe vascular events in migraine patients.
    Velentgas P; Cole JA; Mo J; Sikes CR; Walker AM
    Headache; 2004; 44(7):642-51. PubMed ID: 15209685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Migraine is a risk factor for hypertensive disorders in pregnancy: a prospective cohort study.
    Facchinetti F; Allais G; Nappi RE; D'Amico R; Marozio L; Bertozzi L; Ornati A; Benedetto C
    Cephalalgia; 2009 Mar; 29(3):286-92. PubMed ID: 19220309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of Stroke in Migraineurs Using Triptans. Associations with Age, Sex, Stroke Severity and Subtype.
    Albieri V; Olsen TS; Andersen KK
    EBioMedicine; 2016 Apr; 6():199-205. PubMed ID: 27211561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applying the benefits of the AwM study in the clinic.
    Dodick DW
    Cephalalgia; 2008 Sep; 28 Suppl 2():42-9. PubMed ID: 18715332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.